Jyothi Thundimadathil, Ph.D.

Director of Drug Substance Development CMC at Carmot Therapeutics

Speaker

Jyothi Thundimadathil, Ph.D has over 20 years of experience in the field of peptide and related molecules. This include peptide drug discovery, manufacturing processes and CMC development. He was part of a number of peptide development programs in various roles with special emphasis on improved technologies, process optimization, scale up, cost effective manufacturing and process transfer. Currently he is focusing on the CMC development of various GLP-1 and related molecules at Carmot therapeutics, a member of Roche Group.